Global Immunoadsorption Columns Supply, Demand and Key Producers, 2026-2032
The global Immunoadsorption Columns market size is expected to reach $ 58.44 million by 2032, rising at a market growth of 7.4% CAGR during the forecast period (2026-2032).
Immunoadsorption columns are extracorporeal, single use or regenerable disposable devices used in therapeutic apheresis or plasma purification. After plasma separation, the patient’s plasma is passed through an adsorption bed containing specific or semi specific ligands that selectively bind and remove pathogenic antibodies, immunoglobulins, immune complexes, or defined alloantibodies. This enables rapid reduction of antibody burden in relevant clinical settings and, compared with therapeutic plasma exchange (TPE), typically provides greater target selectivity while reducing reliance on replacement fluids. The core technology paradigm centers on ligand immobilization and hemocompatibility engineering. Common ligands include Protein A affinity ligands, synthetic amino acid or peptide ligands, and glycan structures associated with blood group antigens. The adsorbent matrix is usually a high surface area porous substrate, engineered to balance pressure drop and binding capacity, while controlling leachables and ensuring consistent sterilization and lot to lot performance. Products are commonly delivered as a single use single column or a regenerable dual column system, and are used together with plasma separators, tubing sets, and monitoring equipment as an integrated therapy setup, with commercial charging typically on a per treatment or per course basis. Typical applications span autoimmune and connective tissue diseases, neuroimmunological disorders, and transplant desensitization and antibody mediated rejection (AMR) management. Representative examples include IMMUSORBA PH for autoimmune diseases, IMMUSORBA TR for neurological indications, GLOBAFFIN and TheraSorb Ig omni for broad immunoglobulin removal, and Glycosorb ABO for lowering anti A and anti B antibody titers in ABO incompatible transplantation. Primary customers and users are apheresis teams in tertiary hospitals, particularly in nephrology, rheumatology, neurology, intensive care, and transplant centers. Procedures are most often performed via a plasma pathway with anticoagulation and pressure monitoring. Some products emphasize no need for plasma replacement to reduce infection and allergy related risks, while differentiation across manufacturers is mainly reflected in ligand target spectrum and indication positioning, such as the ImmunoCore and DNA230 product lines.
Immunoadsorption columns are a core consumable in therapeutic apheresis and plasma purification. Their value lies in selectively removing pathogenic factors from separated plasma via immobilized ligands, enabling rapid antibody-burden reduction in autoimmune and neuroimmunological diseases, transplant desensitization, and antibody-mediated rejection scenarios, while in many pathways reducing or avoiding the need for replacement fluids used in therapeutic plasma exchange (TPE). Product differentiation is primarily driven by ligand target spectrum and engineering choices. One route, represented by Protein A–based affinity ligands, emphasizes high-affinity capture of IgG and related antibodies. Another route uses synthetic amino-acid or peptide ligands, highlighting broad immunoglobulin and immune-complex removal while avoiding animal-derived components. A third route applies antigen- or glycan-structure–driven specific adsorption, targeting defined alloantibodies such as anti-A and anti-B. Commercially, suppliers typically deliver either single-use columns or regenerable dual-column systems, and build quality systems around balancing pressure drop and binding capacity, controlling leachables, ensuring sterilization consistency, and maintaining hemocompatibility. In practice, columns are deployed with plasma separators, tubing sets, and monitoring systems as a reproducible therapy setup, and are commonly charged on a per-treatment or per-course basis. Operational focus for clinical teams centers on anticoagulation strategy, pressure monitoring, regeneration workflow, and adverse-event management.
From the supply side, immunoadsorption column R&D and manufacturing capabilities show clear regional concentration. Core production and technical accumulation are anchored in medical-device strongholds such as Germany and Japan, with representative suppliers also emerging in Northern Europe and China. This reflects a high bar that extends beyond mechanical fabrication to encompass materials chemistry, immobilization processes, and regulatory readiness, together with long-cycle clinical evidence building. At the company level, some global device groups extend established therapeutic apheresis platforms into broader product portfolios; some specialists differentiate around a single, well-defined clinical niche via specific antibody removal; and some China-based manufacturers scale product lines rapidly under the pull of domestic registration and hospital demand. The supply structure also highlights parallel technology tracks: broad immunoglobulin removal coexists with highly specific antibody removal, and single-use offerings coexist with regenerable reuse models. These choices materially affect hospital workflow, reprocessing compliance, and cost accounting, and ultimately translate into market differences in indication focus, operational complexity, course organization, and total cost of ownership.
On the commercialization side, regulation and clinical pathways impose strong constraints. Immunoadsorption columns are rarely “globally interchangeable”; instead, markets are segmented by country- or region-specific registrations and labeling, making CE-marked compliance a key enabler for European availability while manufacturers often explicitly note variations in availability by national site. This implies that the same product may correspond to different legal-manufacturer information, instructions for use, and indication statements across markets. Clinical adoption also displays pronounced regional characteristics. For example, Japan has higher utilization density and more established pathways for certain immunoadsorption products, whereas antibody-specific adsorption for transplant desensitization, supported by clear clinical needs and standardized workflows, can more readily expand across multiple countries and centers. In China, market formation is more strongly driven by local registration and hospital blood-purification systems, with domestic brands entering application loops through registration and hospital access and coexisting alongside imported offerings. Overall, market expansion tends to be an iterative, compliance- and evidence-led process: manufacturers must simultaneously address manufacturing consistency and clinical evidence, regional registrations and channel coverage, and system-level integration with equipment and consumable kits to achieve sustainable scale across varying reimbursement environments and departmental structures.
This report studies the global Immunoadsorption Columns demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Immunoadsorption Columns, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Immunoadsorption Columns that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Immunoadsorption Columns total market, 2021-2032, (USD Million)
Global Immunoadsorption Columns total market by region & country, CAGR, 2021-2032, (USD Million)
U.S. VS China: Immunoadsorption Columns total market, key domestic companies, and share, (USD Million)
Global Immunoadsorption Columns revenue by player, revenue and market share 2021-2026, (USD Million)
Global Immunoadsorption Columns total market by Type, CAGR, 2021-2032, (USD Million)
Global Immunoadsorption Columns total market by Application, CAGR, 2021-2032, (USD Million)
This report profiles major players in the global Immunoadsorption Columns market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Asahi Kasei Medical Co., Ltd., Fresenius Medical Care, Glycorex Transplantation AB, Guangzhou Koncen BioScience Co., Ltd., Jafron Biomedical Co., Ltd., Miltenyi Biotec, POCARD Ltd., etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Immunoadsorption Columns market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Immunoadsorption Columns Market, By Region:
1. How big is the global Immunoadsorption Columns market?
2. What is the demand of the global Immunoadsorption Columns market?
3. What is the year over year growth of the global Immunoadsorption Columns market?
4. What is the total value of the global Immunoadsorption Columns market?
5. Who are the Major Players in the global Immunoadsorption Columns market?
6. What are the growth factors driving the market demand?
Immunoadsorption columns are extracorporeal, single use or regenerable disposable devices used in therapeutic apheresis or plasma purification. After plasma separation, the patient’s plasma is passed through an adsorption bed containing specific or semi specific ligands that selectively bind and remove pathogenic antibodies, immunoglobulins, immune complexes, or defined alloantibodies. This enables rapid reduction of antibody burden in relevant clinical settings and, compared with therapeutic plasma exchange (TPE), typically provides greater target selectivity while reducing reliance on replacement fluids. The core technology paradigm centers on ligand immobilization and hemocompatibility engineering. Common ligands include Protein A affinity ligands, synthetic amino acid or peptide ligands, and glycan structures associated with blood group antigens. The adsorbent matrix is usually a high surface area porous substrate, engineered to balance pressure drop and binding capacity, while controlling leachables and ensuring consistent sterilization and lot to lot performance. Products are commonly delivered as a single use single column or a regenerable dual column system, and are used together with plasma separators, tubing sets, and monitoring equipment as an integrated therapy setup, with commercial charging typically on a per treatment or per course basis. Typical applications span autoimmune and connective tissue diseases, neuroimmunological disorders, and transplant desensitization and antibody mediated rejection (AMR) management. Representative examples include IMMUSORBA PH for autoimmune diseases, IMMUSORBA TR for neurological indications, GLOBAFFIN and TheraSorb Ig omni for broad immunoglobulin removal, and Glycosorb ABO for lowering anti A and anti B antibody titers in ABO incompatible transplantation. Primary customers and users are apheresis teams in tertiary hospitals, particularly in nephrology, rheumatology, neurology, intensive care, and transplant centers. Procedures are most often performed via a plasma pathway with anticoagulation and pressure monitoring. Some products emphasize no need for plasma replacement to reduce infection and allergy related risks, while differentiation across manufacturers is mainly reflected in ligand target spectrum and indication positioning, such as the ImmunoCore and DNA230 product lines.
Immunoadsorption columns are a core consumable in therapeutic apheresis and plasma purification. Their value lies in selectively removing pathogenic factors from separated plasma via immobilized ligands, enabling rapid antibody-burden reduction in autoimmune and neuroimmunological diseases, transplant desensitization, and antibody-mediated rejection scenarios, while in many pathways reducing or avoiding the need for replacement fluids used in therapeutic plasma exchange (TPE). Product differentiation is primarily driven by ligand target spectrum and engineering choices. One route, represented by Protein A–based affinity ligands, emphasizes high-affinity capture of IgG and related antibodies. Another route uses synthetic amino-acid or peptide ligands, highlighting broad immunoglobulin and immune-complex removal while avoiding animal-derived components. A third route applies antigen- or glycan-structure–driven specific adsorption, targeting defined alloantibodies such as anti-A and anti-B. Commercially, suppliers typically deliver either single-use columns or regenerable dual-column systems, and build quality systems around balancing pressure drop and binding capacity, controlling leachables, ensuring sterilization consistency, and maintaining hemocompatibility. In practice, columns are deployed with plasma separators, tubing sets, and monitoring systems as a reproducible therapy setup, and are commonly charged on a per-treatment or per-course basis. Operational focus for clinical teams centers on anticoagulation strategy, pressure monitoring, regeneration workflow, and adverse-event management.
From the supply side, immunoadsorption column R&D and manufacturing capabilities show clear regional concentration. Core production and technical accumulation are anchored in medical-device strongholds such as Germany and Japan, with representative suppliers also emerging in Northern Europe and China. This reflects a high bar that extends beyond mechanical fabrication to encompass materials chemistry, immobilization processes, and regulatory readiness, together with long-cycle clinical evidence building. At the company level, some global device groups extend established therapeutic apheresis platforms into broader product portfolios; some specialists differentiate around a single, well-defined clinical niche via specific antibody removal; and some China-based manufacturers scale product lines rapidly under the pull of domestic registration and hospital demand. The supply structure also highlights parallel technology tracks: broad immunoglobulin removal coexists with highly specific antibody removal, and single-use offerings coexist with regenerable reuse models. These choices materially affect hospital workflow, reprocessing compliance, and cost accounting, and ultimately translate into market differences in indication focus, operational complexity, course organization, and total cost of ownership.
On the commercialization side, regulation and clinical pathways impose strong constraints. Immunoadsorption columns are rarely “globally interchangeable”; instead, markets are segmented by country- or region-specific registrations and labeling, making CE-marked compliance a key enabler for European availability while manufacturers often explicitly note variations in availability by national site. This implies that the same product may correspond to different legal-manufacturer information, instructions for use, and indication statements across markets. Clinical adoption also displays pronounced regional characteristics. For example, Japan has higher utilization density and more established pathways for certain immunoadsorption products, whereas antibody-specific adsorption for transplant desensitization, supported by clear clinical needs and standardized workflows, can more readily expand across multiple countries and centers. In China, market formation is more strongly driven by local registration and hospital blood-purification systems, with domestic brands entering application loops through registration and hospital access and coexisting alongside imported offerings. Overall, market expansion tends to be an iterative, compliance- and evidence-led process: manufacturers must simultaneously address manufacturing consistency and clinical evidence, regional registrations and channel coverage, and system-level integration with equipment and consumable kits to achieve sustainable scale across varying reimbursement environments and departmental structures.
This report studies the global Immunoadsorption Columns demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Immunoadsorption Columns, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Immunoadsorption Columns that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Immunoadsorption Columns total market, 2021-2032, (USD Million)
Global Immunoadsorption Columns total market by region & country, CAGR, 2021-2032, (USD Million)
U.S. VS China: Immunoadsorption Columns total market, key domestic companies, and share, (USD Million)
Global Immunoadsorption Columns revenue by player, revenue and market share 2021-2026, (USD Million)
Global Immunoadsorption Columns total market by Type, CAGR, 2021-2032, (USD Million)
Global Immunoadsorption Columns total market by Application, CAGR, 2021-2032, (USD Million)
This report profiles major players in the global Immunoadsorption Columns market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Asahi Kasei Medical Co., Ltd., Fresenius Medical Care, Glycorex Transplantation AB, Guangzhou Koncen BioScience Co., Ltd., Jafron Biomedical Co., Ltd., Miltenyi Biotec, POCARD Ltd., etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Immunoadsorption Columns market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Immunoadsorption Columns Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Single Use Immunoadsorption Columns
- Reuse Immunoadsorption Columns
- Single-ligand
- Composite / Multi-ligand
- Sepharose Carrier Matrix
- Other Inert Polysaccharide Matrix
- Hospitals
- Specialty Clinics
- Academic & Research Centres
- Others
- Asahi Kasei Medical Co., Ltd.
- Fresenius Medical Care
- Glycorex Transplantation AB
- Guangzhou Koncen BioScience Co., Ltd.
- Jafron Biomedical Co., Ltd.
- Miltenyi Biotec
- POCARD Ltd.
1. How big is the global Immunoadsorption Columns market?
2. What is the demand of the global Immunoadsorption Columns market?
3. What is the year over year growth of the global Immunoadsorption Columns market?
4. What is the total value of the global Immunoadsorption Columns market?
5. Who are the Major Players in the global Immunoadsorption Columns market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Immunoadsorption Columns Introduction
1.2 World Immunoadsorption Columns Market Size & Forecast (2021 & 2025 & 2032)
1.3 World Immunoadsorption Columns Total Market by Region (by Headquarter Location)
1.3.1 World Immunoadsorption Columns Market Size by Region (2021-2032), (by Headquarter Location)
1.3.2 United States Based Company Immunoadsorption Columns Revenue (2021-2032)
1.3.3 China Based Company Immunoadsorption Columns Revenue (2021-2032)
1.3.4 Europe Based Company Immunoadsorption Columns Revenue (2021-2032)
1.3.5 Japan Based Company Immunoadsorption Columns Revenue (2021-2032)
1.3.6 South Korea Based Company Immunoadsorption Columns Revenue (2021-2032)
1.3.7 ASEAN Based Company Immunoadsorption Columns Revenue (2021-2032)
1.3.8 India Based Company Immunoadsorption Columns Revenue (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Immunoadsorption Columns Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Major Market Trends
2 DEMAND SUMMARY
2.1 World Immunoadsorption Columns Consumption Value (2021-2032)
2.2 World Immunoadsorption Columns Consumption Value by Region
2.2.1 World Immunoadsorption Columns Consumption Value by Region (2021-2026)
2.2.2 World Immunoadsorption Columns Consumption Value Forecast by Region (2027-2032)
2.3 United States Immunoadsorption Columns Consumption Value (2021-2032)
2.4 China Immunoadsorption Columns Consumption Value (2021-2032)
2.5 Europe Immunoadsorption Columns Consumption Value (2021-2032)
2.6 Japan Immunoadsorption Columns Consumption Value (2021-2032)
2.7 South Korea Immunoadsorption Columns Consumption Value (2021-2032)
2.8 ASEAN Immunoadsorption Columns Consumption Value (2021-2032)
2.9 India Immunoadsorption Columns Consumption Value (2021-2032)
3 WORLD IMMUNOADSORPTION COLUMNS COMPANIES COMPETITIVE ANALYSIS
3.1 World Immunoadsorption Columns Revenue by Player (2021-2026)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Immunoadsorption Columns Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Immunoadsorption Columns in 2025
3.2.3 Global Concentration Ratios (CR8) for Immunoadsorption Columns in 2025
3.3 Immunoadsorption Columns Company Evaluation Quadrant
3.4 Immunoadsorption Columns Market: Overall Company Footprint Analysis
3.4.1 Immunoadsorption Columns Market: Region Footprint
3.4.2 Immunoadsorption Columns Market: Company Product Type Footprint
3.4.3 Immunoadsorption Columns Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Immunoadsorption Columns Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Immunoadsorption Columns Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
4.1.2 United States VS China: Immunoadsorption Columns Revenue Market Share Comparison (2021 & 2025 & 2032)
4.2 United States Based Companies VS China Based Companies: Immunoadsorption Columns Consumption Value Comparison
4.2.1 United States VS China: Immunoadsorption Columns Consumption Value Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Immunoadsorption Columns Consumption Value Market Share Comparison (2021 & 2025 & 2032)
4.3 United States Based Immunoadsorption Columns Companies and Market Share, 2021-2026
4.3.1 United States Based Immunoadsorption Columns Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Immunoadsorption Columns Revenue, (2021-2026)
4.4 China Based Companies Immunoadsorption Columns Revenue and Market Share, 2021-2026
4.4.1 China Based Immunoadsorption Columns Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Immunoadsorption Columns Revenue, (2021-2026)
4.5 Rest of World Based Immunoadsorption Columns Companies and Market Share, 2021-2026
4.5.1 Rest of World Based Immunoadsorption Columns Companies, Headquarters (Province, Country)
4.5.2 Rest of World Based Companies Immunoadsorption Columns Revenue (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Immunoadsorption Columns Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Single Use Immunoadsorption Columns
5.2.2 Reuse Immunoadsorption Columns
5.3 Market Segment by Type
5.3.1 World Immunoadsorption Columns Market Size by Type (2021-2026)
5.3.2 World Immunoadsorption Columns Market Size by Type (2027-2032)
5.3.3 World Immunoadsorption Columns Market Size Market Share by Type (2027-2032)
6 MARKET ANALYSIS BY LIGAND COMPOSITION
6.1 World Immunoadsorption Columns Market Size Overview by Ligand Composition: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Ligand Composition
6.2.1 Single-ligand
6.2.2 Composite / Multi-ligand
6.3 Market Segment by Ligand Composition
6.3.1 World Immunoadsorption Columns Market Size by Ligand Composition (2021-2026)
6.3.2 World Immunoadsorption Columns Market Size by Ligand Composition (2027-2032)
6.3.3 World Immunoadsorption Columns Market Size Market Share by Ligand Composition (2027-2032)
7 MARKET ANALYSIS BY CARRIER MATRIX
7.1 World Immunoadsorption Columns Market Size Overview by Carrier Matrix: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Carrier Matrix
7.2.1 Sepharose Carrier Matrix
7.2.2 Other Inert Polysaccharide Matrix
7.3 Market Segment by Carrier Matrix
7.3.1 World Immunoadsorption Columns Market Size by Carrier Matrix (2021-2026)
7.3.2 World Immunoadsorption Columns Market Size by Carrier Matrix (2027-2032)
7.3.3 World Immunoadsorption Columns Market Size Market Share by Carrier Matrix (2027-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World Immunoadsorption Columns Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Hospitals
8.2.2 Specialty Clinics
8.2.3 Academic & Research Centres
8.2.4 Others
8.3 Market Segment by Application
8.3.1 World Immunoadsorption Columns Market Size by Application (2021-2026)
8.3.2 World Immunoadsorption Columns Market Size by Application (2027-2032)
8.3.3 World Immunoadsorption Columns Market Size Market Share by Application (2021-2032)
9 COMPANY PROFILES
9.1 Asahi Kasei Medical Co., Ltd.
9.1.1 Asahi Kasei Medical Co., Ltd. Details
9.1.2 Asahi Kasei Medical Co., Ltd. Major Business
9.1.3 Asahi Kasei Medical Co., Ltd. Immunoadsorption Columns Product and Services
9.1.4 Asahi Kasei Medical Co., Ltd. Immunoadsorption Columns Revenue, Gross Margin and Market Share (2021-2026)
9.1.5 Asahi Kasei Medical Co., Ltd. Recent Developments/Updates
9.1.6 Asahi Kasei Medical Co., Ltd. Competitive Strengths & Weaknesses
9.2 Fresenius Medical Care
9.2.1 Fresenius Medical Care Details
9.2.2 Fresenius Medical Care Major Business
9.2.3 Fresenius Medical Care Immunoadsorption Columns Product and Services
9.2.4 Fresenius Medical Care Immunoadsorption Columns Revenue, Gross Margin and Market Share (2021-2026)
9.2.5 Fresenius Medical Care Recent Developments/Updates
9.2.6 Fresenius Medical Care Competitive Strengths & Weaknesses
9.3 Glycorex Transplantation AB
9.3.1 Glycorex Transplantation AB Details
9.3.2 Glycorex Transplantation AB Major Business
9.3.3 Glycorex Transplantation AB Immunoadsorption Columns Product and Services
9.3.4 Glycorex Transplantation AB Immunoadsorption Columns Revenue, Gross Margin and Market Share (2021-2026)
9.3.5 Glycorex Transplantation AB Recent Developments/Updates
9.3.6 Glycorex Transplantation AB Competitive Strengths & Weaknesses
9.4 Guangzhou Koncen BioScience Co., Ltd.
9.4.1 Guangzhou Koncen BioScience Co., Ltd. Details
9.4.2 Guangzhou Koncen BioScience Co., Ltd. Major Business
9.4.3 Guangzhou Koncen BioScience Co., Ltd. Immunoadsorption Columns Product and Services
9.4.4 Guangzhou Koncen BioScience Co., Ltd. Immunoadsorption Columns Revenue, Gross Margin and Market Share (2021-2026)
9.4.5 Guangzhou Koncen BioScience Co., Ltd. Recent Developments/Updates
9.4.6 Guangzhou Koncen BioScience Co., Ltd. Competitive Strengths & Weaknesses
9.5 Jafron Biomedical Co., Ltd.
9.5.1 Jafron Biomedical Co., Ltd. Details
9.5.2 Jafron Biomedical Co., Ltd. Major Business
9.5.3 Jafron Biomedical Co., Ltd. Immunoadsorption Columns Product and Services
9.5.4 Jafron Biomedical Co., Ltd. Immunoadsorption Columns Revenue, Gross Margin and Market Share (2021-2026)
9.5.5 Jafron Biomedical Co., Ltd. Recent Developments/Updates
9.5.6 Jafron Biomedical Co., Ltd. Competitive Strengths & Weaknesses
9.6 Miltenyi Biotec
9.6.1 Miltenyi Biotec Details
9.6.2 Miltenyi Biotec Major Business
9.6.3 Miltenyi Biotec Immunoadsorption Columns Product and Services
9.6.4 Miltenyi Biotec Immunoadsorption Columns Revenue, Gross Margin and Market Share (2021-2026)
9.6.5 Miltenyi Biotec Recent Developments/Updates
9.6.6 Miltenyi Biotec Competitive Strengths & Weaknesses
9.7 POCARD Ltd.
9.7.1 POCARD Ltd. Details
9.7.2 POCARD Ltd. Major Business
9.7.3 POCARD Ltd. Immunoadsorption Columns Product and Services
9.7.4 POCARD Ltd. Immunoadsorption Columns Revenue, Gross Margin and Market Share (2021-2026)
9.7.5 POCARD Ltd. Recent Developments/Updates
9.7.6 POCARD Ltd. Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 Immunoadsorption Columns Industry Chain
10.2 Immunoadsorption Columns Upstream Analysis
10.3 Immunoadsorption Columns Midstream Analysis
10.4 Immunoadsorption Columns Downstream Analysis
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
1.1 Immunoadsorption Columns Introduction
1.2 World Immunoadsorption Columns Market Size & Forecast (2021 & 2025 & 2032)
1.3 World Immunoadsorption Columns Total Market by Region (by Headquarter Location)
1.3.1 World Immunoadsorption Columns Market Size by Region (2021-2032), (by Headquarter Location)
1.3.2 United States Based Company Immunoadsorption Columns Revenue (2021-2032)
1.3.3 China Based Company Immunoadsorption Columns Revenue (2021-2032)
1.3.4 Europe Based Company Immunoadsorption Columns Revenue (2021-2032)
1.3.5 Japan Based Company Immunoadsorption Columns Revenue (2021-2032)
1.3.6 South Korea Based Company Immunoadsorption Columns Revenue (2021-2032)
1.3.7 ASEAN Based Company Immunoadsorption Columns Revenue (2021-2032)
1.3.8 India Based Company Immunoadsorption Columns Revenue (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Immunoadsorption Columns Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Major Market Trends
2 DEMAND SUMMARY
2.1 World Immunoadsorption Columns Consumption Value (2021-2032)
2.2 World Immunoadsorption Columns Consumption Value by Region
2.2.1 World Immunoadsorption Columns Consumption Value by Region (2021-2026)
2.2.2 World Immunoadsorption Columns Consumption Value Forecast by Region (2027-2032)
2.3 United States Immunoadsorption Columns Consumption Value (2021-2032)
2.4 China Immunoadsorption Columns Consumption Value (2021-2032)
2.5 Europe Immunoadsorption Columns Consumption Value (2021-2032)
2.6 Japan Immunoadsorption Columns Consumption Value (2021-2032)
2.7 South Korea Immunoadsorption Columns Consumption Value (2021-2032)
2.8 ASEAN Immunoadsorption Columns Consumption Value (2021-2032)
2.9 India Immunoadsorption Columns Consumption Value (2021-2032)
3 WORLD IMMUNOADSORPTION COLUMNS COMPANIES COMPETITIVE ANALYSIS
3.1 World Immunoadsorption Columns Revenue by Player (2021-2026)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Immunoadsorption Columns Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Immunoadsorption Columns in 2025
3.2.3 Global Concentration Ratios (CR8) for Immunoadsorption Columns in 2025
3.3 Immunoadsorption Columns Company Evaluation Quadrant
3.4 Immunoadsorption Columns Market: Overall Company Footprint Analysis
3.4.1 Immunoadsorption Columns Market: Region Footprint
3.4.2 Immunoadsorption Columns Market: Company Product Type Footprint
3.4.3 Immunoadsorption Columns Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Immunoadsorption Columns Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Immunoadsorption Columns Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
4.1.2 United States VS China: Immunoadsorption Columns Revenue Market Share Comparison (2021 & 2025 & 2032)
4.2 United States Based Companies VS China Based Companies: Immunoadsorption Columns Consumption Value Comparison
4.2.1 United States VS China: Immunoadsorption Columns Consumption Value Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Immunoadsorption Columns Consumption Value Market Share Comparison (2021 & 2025 & 2032)
4.3 United States Based Immunoadsorption Columns Companies and Market Share, 2021-2026
4.3.1 United States Based Immunoadsorption Columns Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Immunoadsorption Columns Revenue, (2021-2026)
4.4 China Based Companies Immunoadsorption Columns Revenue and Market Share, 2021-2026
4.4.1 China Based Immunoadsorption Columns Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Immunoadsorption Columns Revenue, (2021-2026)
4.5 Rest of World Based Immunoadsorption Columns Companies and Market Share, 2021-2026
4.5.1 Rest of World Based Immunoadsorption Columns Companies, Headquarters (Province, Country)
4.5.2 Rest of World Based Companies Immunoadsorption Columns Revenue (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Immunoadsorption Columns Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Single Use Immunoadsorption Columns
5.2.2 Reuse Immunoadsorption Columns
5.3 Market Segment by Type
5.3.1 World Immunoadsorption Columns Market Size by Type (2021-2026)
5.3.2 World Immunoadsorption Columns Market Size by Type (2027-2032)
5.3.3 World Immunoadsorption Columns Market Size Market Share by Type (2027-2032)
6 MARKET ANALYSIS BY LIGAND COMPOSITION
6.1 World Immunoadsorption Columns Market Size Overview by Ligand Composition: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Ligand Composition
6.2.1 Single-ligand
6.2.2 Composite / Multi-ligand
6.3 Market Segment by Ligand Composition
6.3.1 World Immunoadsorption Columns Market Size by Ligand Composition (2021-2026)
6.3.2 World Immunoadsorption Columns Market Size by Ligand Composition (2027-2032)
6.3.3 World Immunoadsorption Columns Market Size Market Share by Ligand Composition (2027-2032)
7 MARKET ANALYSIS BY CARRIER MATRIX
7.1 World Immunoadsorption Columns Market Size Overview by Carrier Matrix: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Carrier Matrix
7.2.1 Sepharose Carrier Matrix
7.2.2 Other Inert Polysaccharide Matrix
7.3 Market Segment by Carrier Matrix
7.3.1 World Immunoadsorption Columns Market Size by Carrier Matrix (2021-2026)
7.3.2 World Immunoadsorption Columns Market Size by Carrier Matrix (2027-2032)
7.3.3 World Immunoadsorption Columns Market Size Market Share by Carrier Matrix (2027-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World Immunoadsorption Columns Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Hospitals
8.2.2 Specialty Clinics
8.2.3 Academic & Research Centres
8.2.4 Others
8.3 Market Segment by Application
8.3.1 World Immunoadsorption Columns Market Size by Application (2021-2026)
8.3.2 World Immunoadsorption Columns Market Size by Application (2027-2032)
8.3.3 World Immunoadsorption Columns Market Size Market Share by Application (2021-2032)
9 COMPANY PROFILES
9.1 Asahi Kasei Medical Co., Ltd.
9.1.1 Asahi Kasei Medical Co., Ltd. Details
9.1.2 Asahi Kasei Medical Co., Ltd. Major Business
9.1.3 Asahi Kasei Medical Co., Ltd. Immunoadsorption Columns Product and Services
9.1.4 Asahi Kasei Medical Co., Ltd. Immunoadsorption Columns Revenue, Gross Margin and Market Share (2021-2026)
9.1.5 Asahi Kasei Medical Co., Ltd. Recent Developments/Updates
9.1.6 Asahi Kasei Medical Co., Ltd. Competitive Strengths & Weaknesses
9.2 Fresenius Medical Care
9.2.1 Fresenius Medical Care Details
9.2.2 Fresenius Medical Care Major Business
9.2.3 Fresenius Medical Care Immunoadsorption Columns Product and Services
9.2.4 Fresenius Medical Care Immunoadsorption Columns Revenue, Gross Margin and Market Share (2021-2026)
9.2.5 Fresenius Medical Care Recent Developments/Updates
9.2.6 Fresenius Medical Care Competitive Strengths & Weaknesses
9.3 Glycorex Transplantation AB
9.3.1 Glycorex Transplantation AB Details
9.3.2 Glycorex Transplantation AB Major Business
9.3.3 Glycorex Transplantation AB Immunoadsorption Columns Product and Services
9.3.4 Glycorex Transplantation AB Immunoadsorption Columns Revenue, Gross Margin and Market Share (2021-2026)
9.3.5 Glycorex Transplantation AB Recent Developments/Updates
9.3.6 Glycorex Transplantation AB Competitive Strengths & Weaknesses
9.4 Guangzhou Koncen BioScience Co., Ltd.
9.4.1 Guangzhou Koncen BioScience Co., Ltd. Details
9.4.2 Guangzhou Koncen BioScience Co., Ltd. Major Business
9.4.3 Guangzhou Koncen BioScience Co., Ltd. Immunoadsorption Columns Product and Services
9.4.4 Guangzhou Koncen BioScience Co., Ltd. Immunoadsorption Columns Revenue, Gross Margin and Market Share (2021-2026)
9.4.5 Guangzhou Koncen BioScience Co., Ltd. Recent Developments/Updates
9.4.6 Guangzhou Koncen BioScience Co., Ltd. Competitive Strengths & Weaknesses
9.5 Jafron Biomedical Co., Ltd.
9.5.1 Jafron Biomedical Co., Ltd. Details
9.5.2 Jafron Biomedical Co., Ltd. Major Business
9.5.3 Jafron Biomedical Co., Ltd. Immunoadsorption Columns Product and Services
9.5.4 Jafron Biomedical Co., Ltd. Immunoadsorption Columns Revenue, Gross Margin and Market Share (2021-2026)
9.5.5 Jafron Biomedical Co., Ltd. Recent Developments/Updates
9.5.6 Jafron Biomedical Co., Ltd. Competitive Strengths & Weaknesses
9.6 Miltenyi Biotec
9.6.1 Miltenyi Biotec Details
9.6.2 Miltenyi Biotec Major Business
9.6.3 Miltenyi Biotec Immunoadsorption Columns Product and Services
9.6.4 Miltenyi Biotec Immunoadsorption Columns Revenue, Gross Margin and Market Share (2021-2026)
9.6.5 Miltenyi Biotec Recent Developments/Updates
9.6.6 Miltenyi Biotec Competitive Strengths & Weaknesses
9.7 POCARD Ltd.
9.7.1 POCARD Ltd. Details
9.7.2 POCARD Ltd. Major Business
9.7.3 POCARD Ltd. Immunoadsorption Columns Product and Services
9.7.4 POCARD Ltd. Immunoadsorption Columns Revenue, Gross Margin and Market Share (2021-2026)
9.7.5 POCARD Ltd. Recent Developments/Updates
9.7.6 POCARD Ltd. Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 Immunoadsorption Columns Industry Chain
10.2 Immunoadsorption Columns Upstream Analysis
10.3 Immunoadsorption Columns Midstream Analysis
10.4 Immunoadsorption Columns Downstream Analysis
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
LIST OF TABLES
Table 1. World Immunoadsorption Columns Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Table 2. World Immunoadsorption Columns Revenue by Region (2021-2026) & (USD Million), (by Headquarter Location)
Table 3. World Immunoadsorption Columns Revenue by Region (2027-2032) & (USD Million), (by Headquarter Location)
Table 4. World Immunoadsorption Columns Revenue Market Share by Region (2021-2026), (by Headquarter Location)
Table 5. World Immunoadsorption Columns Revenue Market Share by Region (2027-2032), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Immunoadsorption Columns Consumption Value Growth Rate Forecast by Region (2021 & 2025 & 2032) & (USD Million)
Table 8. World Immunoadsorption Columns Consumption Value by Region (2021-2026) & (USD Million)
Table 9. World Immunoadsorption Columns Consumption Value Forecast by Region (2027-2032) & (USD Million)
Table 10. World Immunoadsorption Columns Revenue by Player (2021-2026) & (USD Million)
Table 11. Revenue Market Share of Key Immunoadsorption Columns Players in 2025
Table 12. World Immunoadsorption Columns Industry Rank of Major Player, Based on Revenue in 2025
Table 13. Global Immunoadsorption Columns Company Evaluation Quadrant
Table 14. Head Office of Key Immunoadsorption Columns Players
Table 15. Immunoadsorption Columns Market: Company Product Type Footprint
Table 16. Immunoadsorption Columns Market: Company Product Application Footprint
Table 17. Immunoadsorption Columns Mergers & Acquisitions Activity
Table 18. United States VS China Immunoadsorption Columns Revenue Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 19. United States VS China Immunoadsorption Columns Consumption Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 20. United States Based Immunoadsorption Columns Companies, Headquarters (States, Country)
Table 21. United States Based Companies Immunoadsorption Columns Revenue, (2021-2026) & (USD Million)
Table 22. United States Based Companies Immunoadsorption Columns Revenue Market Share (2021-2026)
Table 23. China Based Immunoadsorption Columns Companies, Headquarters (Province, Country)
Table 24. China Based Companies Immunoadsorption Columns Revenue, (2021-2026) & (USD Million)
Table 25. China Based Companies Immunoadsorption Columns Revenue Market Share (2021-2026)
Table 26. Rest of World Based Immunoadsorption Columns Companies, Headquarters (Province, Country)
Table 27. Rest of World Based Companies Immunoadsorption Columns Revenue (2021-2026) & (USD Million)
Table 28. Rest of World Based Companies Immunoadsorption Columns Revenue Market Share (2021-2026)
Table 29. World Immunoadsorption Columns Market Size by Type, (USD Million), 2021 & 2025 & 2032
Table 30. World Immunoadsorption Columns Market Size Value by Type (2021-2026) & (USD Million)
Table 31. World Immunoadsorption Columns Market Size by Type (2027-2032) & (USD Million)
Table 32. World Immunoadsorption Columns Market Size by Ligand Composition, (USD Million), 2021 & 2025 & 2032
Table 33. World Immunoadsorption Columns Market Size Value by Ligand Composition (2021-2026) & (USD Million)
Table 34. World Immunoadsorption Columns Market Size by Ligand Composition (2027-2032) & (USD Million)
Table 35. World Immunoadsorption Columns Market Size by Carrier Matrix, (USD Million), 2021 & 2025 & 2032
Table 36. World Immunoadsorption Columns Market Size Value by Carrier Matrix (2021-2026) & (USD Million)
Table 37. World Immunoadsorption Columns Market Size by Carrier Matrix (2027-2032) & (USD Million)
Table 38. World Immunoadsorption Columns Market Size by Application, (USD Million), 2021 & 2025 & 2032
Table 39. World Immunoadsorption Columns Market Size by Application (2021-2026) & (USD Million)
Table 40. World Immunoadsorption Columns Market Size by Application (2027-2032) & (USD Million)
Table 41. Asahi Kasei Medical Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 42. Asahi Kasei Medical Co., Ltd. Major Business
Table 43. Asahi Kasei Medical Co., Ltd. Immunoadsorption Columns Product and Services
Table 44. Asahi Kasei Medical Co., Ltd. Immunoadsorption Columns Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 45. Asahi Kasei Medical Co., Ltd. Recent Developments/Updates
Table 46. Asahi Kasei Medical Co., Ltd. Competitive Strengths & Weaknesses
Table 47. Fresenius Medical Care Basic Information, Manufacturing Base and Competitors
Table 48. Fresenius Medical Care Major Business
Table 49. Fresenius Medical Care Immunoadsorption Columns Product and Services
Table 50. Fresenius Medical Care Immunoadsorption Columns Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 51. Fresenius Medical Care Recent Developments/Updates
Table 52. Fresenius Medical Care Competitive Strengths & Weaknesses
Table 53. Glycorex Transplantation AB Basic Information, Manufacturing Base and Competitors
Table 54. Glycorex Transplantation AB Major Business
Table 55. Glycorex Transplantation AB Immunoadsorption Columns Product and Services
Table 56. Glycorex Transplantation AB Immunoadsorption Columns Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 57. Glycorex Transplantation AB Recent Developments/Updates
Table 58. Glycorex Transplantation AB Competitive Strengths & Weaknesses
Table 59. Guangzhou Koncen BioScience Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 60. Guangzhou Koncen BioScience Co., Ltd. Major Business
Table 61. Guangzhou Koncen BioScience Co., Ltd. Immunoadsorption Columns Product and Services
Table 62. Guangzhou Koncen BioScience Co., Ltd. Immunoadsorption Columns Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 63. Guangzhou Koncen BioScience Co., Ltd. Recent Developments/Updates
Table 64. Guangzhou Koncen BioScience Co., Ltd. Competitive Strengths & Weaknesses
Table 65. Jafron Biomedical Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 66. Jafron Biomedical Co., Ltd. Major Business
Table 67. Jafron Biomedical Co., Ltd. Immunoadsorption Columns Product and Services
Table 68. Jafron Biomedical Co., Ltd. Immunoadsorption Columns Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 69. Jafron Biomedical Co., Ltd. Recent Developments/Updates
Table 70. Jafron Biomedical Co., Ltd. Competitive Strengths & Weaknesses
Table 71. Miltenyi Biotec Basic Information, Manufacturing Base and Competitors
Table 72. Miltenyi Biotec Major Business
Table 73. Miltenyi Biotec Immunoadsorption Columns Product and Services
Table 74. Miltenyi Biotec Immunoadsorption Columns Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 75. Miltenyi Biotec Recent Developments/Updates
Table 76. Miltenyi Biotec Competitive Strengths & Weaknesses
Table 77. POCARD Ltd. Basic Information, Manufacturing Base and Competitors
Table 78. POCARD Ltd. Major Business
Table 79. POCARD Ltd. Immunoadsorption Columns Product and Services
Table 80. POCARD Ltd. Immunoadsorption Columns Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 81. POCARD Ltd. Recent Developments/Updates
Table 82. POCARD Ltd. Competitive Strengths & Weaknesses
Table 83. Global Key Players of Immunoadsorption Columns Upstream (Raw Materials)
Table 84. Global Immunoadsorption Columns Typical Customers
Table 1. World Immunoadsorption Columns Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Table 2. World Immunoadsorption Columns Revenue by Region (2021-2026) & (USD Million), (by Headquarter Location)
Table 3. World Immunoadsorption Columns Revenue by Region (2027-2032) & (USD Million), (by Headquarter Location)
Table 4. World Immunoadsorption Columns Revenue Market Share by Region (2021-2026), (by Headquarter Location)
Table 5. World Immunoadsorption Columns Revenue Market Share by Region (2027-2032), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Immunoadsorption Columns Consumption Value Growth Rate Forecast by Region (2021 & 2025 & 2032) & (USD Million)
Table 8. World Immunoadsorption Columns Consumption Value by Region (2021-2026) & (USD Million)
Table 9. World Immunoadsorption Columns Consumption Value Forecast by Region (2027-2032) & (USD Million)
Table 10. World Immunoadsorption Columns Revenue by Player (2021-2026) & (USD Million)
Table 11. Revenue Market Share of Key Immunoadsorption Columns Players in 2025
Table 12. World Immunoadsorption Columns Industry Rank of Major Player, Based on Revenue in 2025
Table 13. Global Immunoadsorption Columns Company Evaluation Quadrant
Table 14. Head Office of Key Immunoadsorption Columns Players
Table 15. Immunoadsorption Columns Market: Company Product Type Footprint
Table 16. Immunoadsorption Columns Market: Company Product Application Footprint
Table 17. Immunoadsorption Columns Mergers & Acquisitions Activity
Table 18. United States VS China Immunoadsorption Columns Revenue Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 19. United States VS China Immunoadsorption Columns Consumption Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 20. United States Based Immunoadsorption Columns Companies, Headquarters (States, Country)
Table 21. United States Based Companies Immunoadsorption Columns Revenue, (2021-2026) & (USD Million)
Table 22. United States Based Companies Immunoadsorption Columns Revenue Market Share (2021-2026)
Table 23. China Based Immunoadsorption Columns Companies, Headquarters (Province, Country)
Table 24. China Based Companies Immunoadsorption Columns Revenue, (2021-2026) & (USD Million)
Table 25. China Based Companies Immunoadsorption Columns Revenue Market Share (2021-2026)
Table 26. Rest of World Based Immunoadsorption Columns Companies, Headquarters (Province, Country)
Table 27. Rest of World Based Companies Immunoadsorption Columns Revenue (2021-2026) & (USD Million)
Table 28. Rest of World Based Companies Immunoadsorption Columns Revenue Market Share (2021-2026)
Table 29. World Immunoadsorption Columns Market Size by Type, (USD Million), 2021 & 2025 & 2032
Table 30. World Immunoadsorption Columns Market Size Value by Type (2021-2026) & (USD Million)
Table 31. World Immunoadsorption Columns Market Size by Type (2027-2032) & (USD Million)
Table 32. World Immunoadsorption Columns Market Size by Ligand Composition, (USD Million), 2021 & 2025 & 2032
Table 33. World Immunoadsorption Columns Market Size Value by Ligand Composition (2021-2026) & (USD Million)
Table 34. World Immunoadsorption Columns Market Size by Ligand Composition (2027-2032) & (USD Million)
Table 35. World Immunoadsorption Columns Market Size by Carrier Matrix, (USD Million), 2021 & 2025 & 2032
Table 36. World Immunoadsorption Columns Market Size Value by Carrier Matrix (2021-2026) & (USD Million)
Table 37. World Immunoadsorption Columns Market Size by Carrier Matrix (2027-2032) & (USD Million)
Table 38. World Immunoadsorption Columns Market Size by Application, (USD Million), 2021 & 2025 & 2032
Table 39. World Immunoadsorption Columns Market Size by Application (2021-2026) & (USD Million)
Table 40. World Immunoadsorption Columns Market Size by Application (2027-2032) & (USD Million)
Table 41. Asahi Kasei Medical Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 42. Asahi Kasei Medical Co., Ltd. Major Business
Table 43. Asahi Kasei Medical Co., Ltd. Immunoadsorption Columns Product and Services
Table 44. Asahi Kasei Medical Co., Ltd. Immunoadsorption Columns Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 45. Asahi Kasei Medical Co., Ltd. Recent Developments/Updates
Table 46. Asahi Kasei Medical Co., Ltd. Competitive Strengths & Weaknesses
Table 47. Fresenius Medical Care Basic Information, Manufacturing Base and Competitors
Table 48. Fresenius Medical Care Major Business
Table 49. Fresenius Medical Care Immunoadsorption Columns Product and Services
Table 50. Fresenius Medical Care Immunoadsorption Columns Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 51. Fresenius Medical Care Recent Developments/Updates
Table 52. Fresenius Medical Care Competitive Strengths & Weaknesses
Table 53. Glycorex Transplantation AB Basic Information, Manufacturing Base and Competitors
Table 54. Glycorex Transplantation AB Major Business
Table 55. Glycorex Transplantation AB Immunoadsorption Columns Product and Services
Table 56. Glycorex Transplantation AB Immunoadsorption Columns Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 57. Glycorex Transplantation AB Recent Developments/Updates
Table 58. Glycorex Transplantation AB Competitive Strengths & Weaknesses
Table 59. Guangzhou Koncen BioScience Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 60. Guangzhou Koncen BioScience Co., Ltd. Major Business
Table 61. Guangzhou Koncen BioScience Co., Ltd. Immunoadsorption Columns Product and Services
Table 62. Guangzhou Koncen BioScience Co., Ltd. Immunoadsorption Columns Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 63. Guangzhou Koncen BioScience Co., Ltd. Recent Developments/Updates
Table 64. Guangzhou Koncen BioScience Co., Ltd. Competitive Strengths & Weaknesses
Table 65. Jafron Biomedical Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 66. Jafron Biomedical Co., Ltd. Major Business
Table 67. Jafron Biomedical Co., Ltd. Immunoadsorption Columns Product and Services
Table 68. Jafron Biomedical Co., Ltd. Immunoadsorption Columns Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 69. Jafron Biomedical Co., Ltd. Recent Developments/Updates
Table 70. Jafron Biomedical Co., Ltd. Competitive Strengths & Weaknesses
Table 71. Miltenyi Biotec Basic Information, Manufacturing Base and Competitors
Table 72. Miltenyi Biotec Major Business
Table 73. Miltenyi Biotec Immunoadsorption Columns Product and Services
Table 74. Miltenyi Biotec Immunoadsorption Columns Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 75. Miltenyi Biotec Recent Developments/Updates
Table 76. Miltenyi Biotec Competitive Strengths & Weaknesses
Table 77. POCARD Ltd. Basic Information, Manufacturing Base and Competitors
Table 78. POCARD Ltd. Major Business
Table 79. POCARD Ltd. Immunoadsorption Columns Product and Services
Table 80. POCARD Ltd. Immunoadsorption Columns Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 81. POCARD Ltd. Recent Developments/Updates
Table 82. POCARD Ltd. Competitive Strengths & Weaknesses
Table 83. Global Key Players of Immunoadsorption Columns Upstream (Raw Materials)
Table 84. Global Immunoadsorption Columns Typical Customers
LIST OF FIGURES
Figure 1. Immunoadsorption Columns Picture
Figure 2. World Immunoadsorption Columns Total Revenue: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Immunoadsorption Columns Total Revenue (2021-2032) & (USD Million)
Figure 4. World Immunoadsorption Columns Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Figure 5. World Immunoadsorption Columns Revenue Market Share by Region (2021-2032), (by Headquarter Location)
Figure 6. United States Based Company Immunoadsorption Columns Revenue (2021-2032) & (USD Million)
Figure 7. China Based Company Immunoadsorption Columns Revenue (2021-2032) & (USD Million)
Figure 8. Europe Based Company Immunoadsorption Columns Revenue (2021-2032) & (USD Million)
Figure 9. Japan Based Company Immunoadsorption Columns Revenue (2021-2032) & (USD Million)
Figure 10. South Korea Based Company Immunoadsorption Columns Revenue (2021-2032) & (USD Million)
Figure 11. ASEAN Based Company Immunoadsorption Columns Revenue (2021-2032) & (USD Million)
Figure 12. India Based Company Immunoadsorption Columns Revenue (2021-2032) & (USD Million)
Figure 13. Immunoadsorption Columns Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Immunoadsorption Columns Consumption Value (2021-2032) & (USD Million)
Figure 16. World Immunoadsorption Columns Consumption Value Market Share by Region (2021-2032)
Figure 17. United States Immunoadsorption Columns Consumption Value (2021-2032) & (USD Million)
Figure 18. China Immunoadsorption Columns Consumption Value (2021-2032) & (USD Million)
Figure 19. Europe Immunoadsorption Columns Consumption Value (2021-2032) & (USD Million)
Figure 20. Japan Immunoadsorption Columns Consumption Value (2021-2032) & (USD Million)
Figure 21. South Korea Immunoadsorption Columns Consumption Value (2021-2032) & (USD Million)
Figure 22. ASEAN Immunoadsorption Columns Consumption Value (2021-2032) & (USD Million)
Figure 23. India Immunoadsorption Columns Consumption Value (2021-2032) & (USD Million)
Figure 24. Producer Shipments of Immunoadsorption Columns by Player Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for Immunoadsorption Columns Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for Immunoadsorption Columns Markets in 2025
Figure 27. United States VS China: Immunoadsorption Columns Revenue Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Immunoadsorption Columns Consumption Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. World Immunoadsorption Columns Market Size by Type, (USD Million), 2021 & 2025 & 2032
Figure 30. World Immunoadsorption Columns Market Size Market Share by Type in 2025
Figure 31. Single Use Immunoadsorption Columns
Figure 32. Reuse Immunoadsorption Columns
Figure 33. World Immunoadsorption Columns Market Size Market Share by Type (2021-2032)
Figure 34. World Immunoadsorption Columns Market Size by Ligand Composition, (USD Million), 2021 & 2025 & 2032
Figure 35. World Immunoadsorption Columns Market Size Market Share by Ligand Composition in 2025
Figure 36. Single-ligand
Figure 37. Composite / Multi-ligand
Figure 38. World Immunoadsorption Columns Market Size Market Share by Ligand Composition (2021-2032)
Figure 39. World Immunoadsorption Columns Market Size by Carrier Matrix, (USD Million), 2021 & 2025 & 2032
Figure 40. World Immunoadsorption Columns Market Size Market Share by Carrier Matrix in 2025
Figure 41. Sepharose Carrier Matrix
Figure 42. Other Inert Polysaccharide Matrix
Figure 43. World Immunoadsorption Columns Market Size Market Share by Carrier Matrix (2021-2032)
Figure 44. World Immunoadsorption Columns Market Size by Application, (USD Million), 2021 & 2025 & 2032
Figure 45. World Immunoadsorption Columns Market Size Market Share by Application in 2025
Figure 46. Hospitals
Figure 47. Specialty Clinics
Figure 48. Academic & Research Centres
Figure 49. Others
Figure 50. World Immunoadsorption Columns Market Size Market Share by Application (2021-2032)
Figure 51. Immunoadsorption Columns Industrial Chain
Figure 52. Methodology
Figure 53. Research Process and Data Source
Figure 1. Immunoadsorption Columns Picture
Figure 2. World Immunoadsorption Columns Total Revenue: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Immunoadsorption Columns Total Revenue (2021-2032) & (USD Million)
Figure 4. World Immunoadsorption Columns Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Figure 5. World Immunoadsorption Columns Revenue Market Share by Region (2021-2032), (by Headquarter Location)
Figure 6. United States Based Company Immunoadsorption Columns Revenue (2021-2032) & (USD Million)
Figure 7. China Based Company Immunoadsorption Columns Revenue (2021-2032) & (USD Million)
Figure 8. Europe Based Company Immunoadsorption Columns Revenue (2021-2032) & (USD Million)
Figure 9. Japan Based Company Immunoadsorption Columns Revenue (2021-2032) & (USD Million)
Figure 10. South Korea Based Company Immunoadsorption Columns Revenue (2021-2032) & (USD Million)
Figure 11. ASEAN Based Company Immunoadsorption Columns Revenue (2021-2032) & (USD Million)
Figure 12. India Based Company Immunoadsorption Columns Revenue (2021-2032) & (USD Million)
Figure 13. Immunoadsorption Columns Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Immunoadsorption Columns Consumption Value (2021-2032) & (USD Million)
Figure 16. World Immunoadsorption Columns Consumption Value Market Share by Region (2021-2032)
Figure 17. United States Immunoadsorption Columns Consumption Value (2021-2032) & (USD Million)
Figure 18. China Immunoadsorption Columns Consumption Value (2021-2032) & (USD Million)
Figure 19. Europe Immunoadsorption Columns Consumption Value (2021-2032) & (USD Million)
Figure 20. Japan Immunoadsorption Columns Consumption Value (2021-2032) & (USD Million)
Figure 21. South Korea Immunoadsorption Columns Consumption Value (2021-2032) & (USD Million)
Figure 22. ASEAN Immunoadsorption Columns Consumption Value (2021-2032) & (USD Million)
Figure 23. India Immunoadsorption Columns Consumption Value (2021-2032) & (USD Million)
Figure 24. Producer Shipments of Immunoadsorption Columns by Player Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for Immunoadsorption Columns Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for Immunoadsorption Columns Markets in 2025
Figure 27. United States VS China: Immunoadsorption Columns Revenue Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Immunoadsorption Columns Consumption Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. World Immunoadsorption Columns Market Size by Type, (USD Million), 2021 & 2025 & 2032
Figure 30. World Immunoadsorption Columns Market Size Market Share by Type in 2025
Figure 31. Single Use Immunoadsorption Columns
Figure 32. Reuse Immunoadsorption Columns
Figure 33. World Immunoadsorption Columns Market Size Market Share by Type (2021-2032)
Figure 34. World Immunoadsorption Columns Market Size by Ligand Composition, (USD Million), 2021 & 2025 & 2032
Figure 35. World Immunoadsorption Columns Market Size Market Share by Ligand Composition in 2025
Figure 36. Single-ligand
Figure 37. Composite / Multi-ligand
Figure 38. World Immunoadsorption Columns Market Size Market Share by Ligand Composition (2021-2032)
Figure 39. World Immunoadsorption Columns Market Size by Carrier Matrix, (USD Million), 2021 & 2025 & 2032
Figure 40. World Immunoadsorption Columns Market Size Market Share by Carrier Matrix in 2025
Figure 41. Sepharose Carrier Matrix
Figure 42. Other Inert Polysaccharide Matrix
Figure 43. World Immunoadsorption Columns Market Size Market Share by Carrier Matrix (2021-2032)
Figure 44. World Immunoadsorption Columns Market Size by Application, (USD Million), 2021 & 2025 & 2032
Figure 45. World Immunoadsorption Columns Market Size Market Share by Application in 2025
Figure 46. Hospitals
Figure 47. Specialty Clinics
Figure 48. Academic & Research Centres
Figure 49. Others
Figure 50. World Immunoadsorption Columns Market Size Market Share by Application (2021-2032)
Figure 51. Immunoadsorption Columns Industrial Chain
Figure 52. Methodology
Figure 53. Research Process and Data Source
